 NEW YORK, NY, Jan. 15, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Tauriga Sciences, Inc. OTCQB: TAUG Tauriga or the Company, a revenue generating, diversified life sciences company, with a proprietary line of CBD CBG infused Supplement chewing gums Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant as well as an ongoing Pharmaceutical Development initiative, today announced that, in compliance with the Florida Business Corporations Act, and its governing corporate documents and rules relating thereto, the Companys board will take immediate steps to begin increasing the number of members serving on its Board of Directors Board to seven, with a majority of such resulting Board being independent members. Additionally, the Company will promptly begin implementing more stringent and improved corporate governance Governance protocols and policies. We intend to implement and complete these steps by March 31, 2021 or as soon as practicable. In addition to appointing qualified and experienced new board members, the Company has also committed to focus on diversity in appointing one or more members to our Board. As required under applicable SEC disclosure rules, we will timely report any new board appointments as they occur either via Form 8-K or such other quarterly or annual report, as the case may be. 